Cibus shares surge 10.23% intraday after pricing $20M public offering to fund rice traits and working capital.

Cibus Inc. (Nasdaq: CBUS) surged 10.23% intraday following the announcement of a $20.0 million public offering of 13.3 million Class A shares at $1.50 per share, with board members committing to purchase 1 million shares. The underwriter’s option to buy an additional 2 million shares could raise up to $23.0 million, with proceeds earmarked for working capital, rice weed management trait development, and paying accrued expenses. The offering, priced under a pre-existing shelf registration, signals investor confidence in Cibus’ gene-editing technology and strategic focus on agricultural productivity. While one report noted an initial decline in the stock.